Technical Data
E3440-12A
Epstein Barr Virus, Latent Membrane Protein 2A (EBV LMP2A, Human Herpes virus 4, HHV4, Latent Membrane Protein 2, LMP2, Terminal Protein)
Description:
Applications:
Suitable for use in Immunohistochemistry (paraffin) and Western Blot. Other applications not tested.

Recommended Dilution:
Immunohistochemistry (paraffin): Requires antigen retrieval using heat treatment prior to staining of paraffin sections.
Western Blot: 1:100-1:1,000
Optimal dilutions to be determined by the researcher.

Hybridoma:
P3X63.Ag8.653 myeloma cells with spleen cells from Lou/c rats.

Storage and Stability:
May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, add sterile 40-50% glycerol, aliquot and store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
MabIgG110C126Affinity Purified
SizeStorageShippingSourceHost
250ug-20°CBlue IceRat
Concentration:
~1mg/ml
Immunogen:
Bacterial TrpE-LMP2A fusion protein
Purity:
Purified by Protein G affinity chromatography.
Form
Supplied as a liquid in PBS, pH 7.4, 0.09% sodium azide.
Specificity:
Recognizes latent membrane protein 2A (LMP2A) of Epstein-Barr virus (EBV). Does not cross react with LMP2B.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Niedobitek, G. et al. (1997) Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin’s disease and infectious mononucleosis. Blood. 90: 1664-1672